Erlotinib plus gemcitabinecompared with gemcitabinealonein patients with advanced pancreatic cancer:a phase Ⅲ trial of the National Cancer Institute of Canada Clinical Trials Group .Cetuximab,a monoclonal antibody targeting the epidermalgrowth factor rece ......